5. Results of network meta‐analysis for outcome skeletal‐related events: pathological fractures. Prediction intervals. Treatments are ordered by P‐score (descending).
95% prediction intervals (risk ratios, random‐effects model) | ||||
Denosumab | [ 0.73, 1.48 ] | [ 0.36, 5.13 ] | [ 1.01, 3.34 ] | [ 0.78, 6.41 ] |
[ 0.67, 1.36 ] | Zoledronic acid | [ 0.37, 4.69 ] | [ 1.09, 2.86 ] | [ 0.8, 5.79 ] |
[ 0.19, 2.75 ] | [ 0.21, 2.74 ] | Clodronate | [ 0.39, 4.63 ] | [ 0.36, 7.41 ] |
[ 0.3, 0.99 ] | [ 0.35, 0.92 ] | [ 0.22, 2.54 ] | No treatment/placebo | [ 0.51, 2.89 ] |
[ 0.16, 1.28 ] | [ 0.17, 1.25 ] | [ 0.13, 2.75 ] | [ 0.35, 1.95 ] | Pamidronate |